Bristol-Myers Squibb: A phase III ALOFT-IPF trial evaluating ADMILPARANT for treating idiopathic pulmonary fibrosis in adults reached a major end.

Zhitongcaijing · 2d ago
Bristol-Myers Squibb: A phase III ALOFT-IPF trial evaluating ADMILPARANT for treating idiopathic pulmonary fibrosis in adults reached a major end.